Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | UBN2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | C3orf70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | TSR1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | HDX | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | NR4A1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
mRNA | KIAA0430 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | PARVG | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | LRRC10B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | IMPG1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
mRNA | C16orf46 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |